US 9809623
α4β7 peptide monomer and dimer antagonists
granted A61KA61K38/00A61P
Quick answer
US patent 9809623 (α4β7 peptide monomer and dimer antagonists) held by Protagonist Therapeutics, Inc. expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Protagonist Therapeutics, Inc.
- Grant date
- Tue Nov 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K38/00, A61P, A61P1/00, A61P1/04